Influence of Age and Histology on Outcome in Adult Non-Hodgkin Lymphoma Patients Undergoing Autologous Hematopoietic Cell Transplantation (HCT): A Report from The Center For International Blood & Marrow Transplant Research (CIBMTR)

Hillard M. Lazarus, Jeanette Carreras, Christian Boudreau, Fausto R. Loberiza, James O. Armitage, Brian J. Bolwell, César O. Freytes, Robert Peter Gale, John Gibson, Gregory A. Hale, David J. Inwards, Charles F. LeMaistre, Dipnarine Maharaj, David I. Marks, Alan M. Miller, Santiago Pavlovsky, Harry C. Schouten, Koen van Besien, Julie M. Vose, Jacob D. BitranIssa F. Khouri, Philip L. McCarthy, Hongmei Yu, Philip Rowlings, Derek S. Serna, Mary M. Horowitz, J. Douglas Rizzo

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

To compare the clinical outcomes of older (age ≥55 years) non-Hodgkin lymphoma (NHL) patients with younger NHL patients (<55 years) receiving autologous hematopoietic cell transplantation (HCT) while adjusting for patient-, disease-, and treatment-related variables, we compared autologous HCT outcomes in 805 NHL patients aged ≥55 years to 1949 NHL patients <55 years during the years 1990-2000 using data reported to the Center for International Blood and Marrow Transplant Research (CIBMTR). In multivariate analysis, older patients with aggressive histologies were 1.86 times (95% confidence interval [CI] 1.43-2.43, P < .001) more likely than younger patients to experience treatment-related mortality (TRM). Relative death risks were 1.33 times (CI 1.04-1.71, P = .024) and 1.50 times (CI 1.33-16.9, P < .001) higher in older compared to younger patients with follicular grade I/II and aggressive histologies, respectively. Autologous HCT in older NHL patients is feasible, but most disease-related outcomes are statistically inferior to younger patients. Studies addressing supportive care particular to older patients, who are most likely to benefit from this approach, are recommended.

Original languageEnglish (US)
Pages (from-to)1323-1333
Number of pages11
JournalBiology of Blood and Marrow Transplantation
Volume14
Issue number12
DOIs
StatePublished - Dec 2008

Fingerprint

Cell Transplantation
Hodgkin Disease
Non-Hodgkin's Lymphoma
Histology
Bone Marrow
Transplants
Research
Confidence Intervals
Multivariate Analysis

Keywords

  • Autologous HCT
  • Elderly
  • Non-Hodgkin lymphoma
  • Relapse
  • Second complete remission

ASJC Scopus subject areas

  • Transplantation
  • Hematology

Cite this

Influence of Age and Histology on Outcome in Adult Non-Hodgkin Lymphoma Patients Undergoing Autologous Hematopoietic Cell Transplantation (HCT) : A Report from The Center For International Blood & Marrow Transplant Research (CIBMTR). / Lazarus, Hillard M.; Carreras, Jeanette; Boudreau, Christian; Loberiza, Fausto R.; Armitage, James O.; Bolwell, Brian J.; Freytes, César O.; Gale, Robert Peter; Gibson, John; Hale, Gregory A.; Inwards, David J.; LeMaistre, Charles F.; Maharaj, Dipnarine; Marks, David I.; Miller, Alan M.; Pavlovsky, Santiago; Schouten, Harry C.; van Besien, Koen; Vose, Julie M.; Bitran, Jacob D.; Khouri, Issa F.; McCarthy, Philip L.; Yu, Hongmei; Rowlings, Philip; Serna, Derek S.; Horowitz, Mary M.; Rizzo, J. Douglas.

In: Biology of Blood and Marrow Transplantation, Vol. 14, No. 12, 12.2008, p. 1323-1333.

Research output: Contribution to journalArticle

Lazarus, HM, Carreras, J, Boudreau, C, Loberiza, FR, Armitage, JO, Bolwell, BJ, Freytes, CO, Gale, RP, Gibson, J, Hale, GA, Inwards, DJ, LeMaistre, CF, Maharaj, D, Marks, DI, Miller, AM, Pavlovsky, S, Schouten, HC, van Besien, K, Vose, JM, Bitran, JD, Khouri, IF, McCarthy, PL, Yu, H, Rowlings, P, Serna, DS, Horowitz, MM & Rizzo, JD 2008, 'Influence of Age and Histology on Outcome in Adult Non-Hodgkin Lymphoma Patients Undergoing Autologous Hematopoietic Cell Transplantation (HCT): A Report from The Center For International Blood & Marrow Transplant Research (CIBMTR)', Biology of Blood and Marrow Transplantation, vol. 14, no. 12, pp. 1323-1333. https://doi.org/10.1016/j.bbmt.2008.09.008
Lazarus, Hillard M. ; Carreras, Jeanette ; Boudreau, Christian ; Loberiza, Fausto R. ; Armitage, James O. ; Bolwell, Brian J. ; Freytes, César O. ; Gale, Robert Peter ; Gibson, John ; Hale, Gregory A. ; Inwards, David J. ; LeMaistre, Charles F. ; Maharaj, Dipnarine ; Marks, David I. ; Miller, Alan M. ; Pavlovsky, Santiago ; Schouten, Harry C. ; van Besien, Koen ; Vose, Julie M. ; Bitran, Jacob D. ; Khouri, Issa F. ; McCarthy, Philip L. ; Yu, Hongmei ; Rowlings, Philip ; Serna, Derek S. ; Horowitz, Mary M. ; Rizzo, J. Douglas. / Influence of Age and Histology on Outcome in Adult Non-Hodgkin Lymphoma Patients Undergoing Autologous Hematopoietic Cell Transplantation (HCT) : A Report from The Center For International Blood & Marrow Transplant Research (CIBMTR). In: Biology of Blood and Marrow Transplantation. 2008 ; Vol. 14, No. 12. pp. 1323-1333.
@article{bacf1f2d10974aadae588114b1a847e7,
title = "Influence of Age and Histology on Outcome in Adult Non-Hodgkin Lymphoma Patients Undergoing Autologous Hematopoietic Cell Transplantation (HCT): A Report from The Center For International Blood & Marrow Transplant Research (CIBMTR)",
abstract = "To compare the clinical outcomes of older (age ≥55 years) non-Hodgkin lymphoma (NHL) patients with younger NHL patients (<55 years) receiving autologous hematopoietic cell transplantation (HCT) while adjusting for patient-, disease-, and treatment-related variables, we compared autologous HCT outcomes in 805 NHL patients aged ≥55 years to 1949 NHL patients <55 years during the years 1990-2000 using data reported to the Center for International Blood and Marrow Transplant Research (CIBMTR). In multivariate analysis, older patients with aggressive histologies were 1.86 times (95{\%} confidence interval [CI] 1.43-2.43, P < .001) more likely than younger patients to experience treatment-related mortality (TRM). Relative death risks were 1.33 times (CI 1.04-1.71, P = .024) and 1.50 times (CI 1.33-16.9, P < .001) higher in older compared to younger patients with follicular grade I/II and aggressive histologies, respectively. Autologous HCT in older NHL patients is feasible, but most disease-related outcomes are statistically inferior to younger patients. Studies addressing supportive care particular to older patients, who are most likely to benefit from this approach, are recommended.",
keywords = "Autologous HCT, Elderly, Non-Hodgkin lymphoma, Relapse, Second complete remission",
author = "Lazarus, {Hillard M.} and Jeanette Carreras and Christian Boudreau and Loberiza, {Fausto R.} and Armitage, {James O.} and Bolwell, {Brian J.} and Freytes, {C{\'e}sar O.} and Gale, {Robert Peter} and John Gibson and Hale, {Gregory A.} and Inwards, {David J.} and LeMaistre, {Charles F.} and Dipnarine Maharaj and Marks, {David I.} and Miller, {Alan M.} and Santiago Pavlovsky and Schouten, {Harry C.} and {van Besien}, Koen and Vose, {Julie M.} and Bitran, {Jacob D.} and Khouri, {Issa F.} and McCarthy, {Philip L.} and Hongmei Yu and Philip Rowlings and Serna, {Derek S.} and Horowitz, {Mary M.} and Rizzo, {J. Douglas}",
year = "2008",
month = "12",
doi = "10.1016/j.bbmt.2008.09.008",
language = "English (US)",
volume = "14",
pages = "1323--1333",
journal = "Biology of Blood and Marrow Transplantation",
issn = "1083-8791",
publisher = "Elsevier Inc.",
number = "12",

}

TY - JOUR

T1 - Influence of Age and Histology on Outcome in Adult Non-Hodgkin Lymphoma Patients Undergoing Autologous Hematopoietic Cell Transplantation (HCT)

T2 - A Report from The Center For International Blood & Marrow Transplant Research (CIBMTR)

AU - Lazarus, Hillard M.

AU - Carreras, Jeanette

AU - Boudreau, Christian

AU - Loberiza, Fausto R.

AU - Armitage, James O.

AU - Bolwell, Brian J.

AU - Freytes, César O.

AU - Gale, Robert Peter

AU - Gibson, John

AU - Hale, Gregory A.

AU - Inwards, David J.

AU - LeMaistre, Charles F.

AU - Maharaj, Dipnarine

AU - Marks, David I.

AU - Miller, Alan M.

AU - Pavlovsky, Santiago

AU - Schouten, Harry C.

AU - van Besien, Koen

AU - Vose, Julie M.

AU - Bitran, Jacob D.

AU - Khouri, Issa F.

AU - McCarthy, Philip L.

AU - Yu, Hongmei

AU - Rowlings, Philip

AU - Serna, Derek S.

AU - Horowitz, Mary M.

AU - Rizzo, J. Douglas

PY - 2008/12

Y1 - 2008/12

N2 - To compare the clinical outcomes of older (age ≥55 years) non-Hodgkin lymphoma (NHL) patients with younger NHL patients (<55 years) receiving autologous hematopoietic cell transplantation (HCT) while adjusting for patient-, disease-, and treatment-related variables, we compared autologous HCT outcomes in 805 NHL patients aged ≥55 years to 1949 NHL patients <55 years during the years 1990-2000 using data reported to the Center for International Blood and Marrow Transplant Research (CIBMTR). In multivariate analysis, older patients with aggressive histologies were 1.86 times (95% confidence interval [CI] 1.43-2.43, P < .001) more likely than younger patients to experience treatment-related mortality (TRM). Relative death risks were 1.33 times (CI 1.04-1.71, P = .024) and 1.50 times (CI 1.33-16.9, P < .001) higher in older compared to younger patients with follicular grade I/II and aggressive histologies, respectively. Autologous HCT in older NHL patients is feasible, but most disease-related outcomes are statistically inferior to younger patients. Studies addressing supportive care particular to older patients, who are most likely to benefit from this approach, are recommended.

AB - To compare the clinical outcomes of older (age ≥55 years) non-Hodgkin lymphoma (NHL) patients with younger NHL patients (<55 years) receiving autologous hematopoietic cell transplantation (HCT) while adjusting for patient-, disease-, and treatment-related variables, we compared autologous HCT outcomes in 805 NHL patients aged ≥55 years to 1949 NHL patients <55 years during the years 1990-2000 using data reported to the Center for International Blood and Marrow Transplant Research (CIBMTR). In multivariate analysis, older patients with aggressive histologies were 1.86 times (95% confidence interval [CI] 1.43-2.43, P < .001) more likely than younger patients to experience treatment-related mortality (TRM). Relative death risks were 1.33 times (CI 1.04-1.71, P = .024) and 1.50 times (CI 1.33-16.9, P < .001) higher in older compared to younger patients with follicular grade I/II and aggressive histologies, respectively. Autologous HCT in older NHL patients is feasible, but most disease-related outcomes are statistically inferior to younger patients. Studies addressing supportive care particular to older patients, who are most likely to benefit from this approach, are recommended.

KW - Autologous HCT

KW - Elderly

KW - Non-Hodgkin lymphoma

KW - Relapse

KW - Second complete remission

UR - http://www.scopus.com/inward/record.url?scp=56749184062&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=56749184062&partnerID=8YFLogxK

U2 - 10.1016/j.bbmt.2008.09.008

DO - 10.1016/j.bbmt.2008.09.008

M3 - Article

C2 - 19041053

AN - SCOPUS:56749184062

VL - 14

SP - 1323

EP - 1333

JO - Biology of Blood and Marrow Transplantation

JF - Biology of Blood and Marrow Transplantation

SN - 1083-8791

IS - 12

ER -